2020 Bionow Oncology Conference

2020 Bionow Oncology Conference

Digital Event
Wednesday 4th - Thursday 5th November 2020

About

The prevention of cancer and development of more effective strategies to detect precursors and early-stage cancers, when treatment may be most effective, remain critical societal goals.

The 2020 Bionow Oncology Conference will present the problems that we face with prevention and early diagnosis and discuss the latest advances to address these challenges and translate the science into better care for the cancer patient. In addition to leading experts we will also hear about this challenge from the patient’s perspective.

Cancer is always a complex question and there are no simple answers which is why it’s important to hear from those at the cutting edge of developments.

Conference Agenda

  • Virtual Reception Area Opens

  • Conference Welcome

    Geoff Davison, CEO, Bionow

  • Keynote Speaker

    Allan Jordan, Director - Oncology Drug Discovery, Sygnature Discovery

  • Cancer Diagnosis

    Chair: Jonathan Perkins, Associate Director Personalised Healthcare, QIAGEN
    Speakers
    Will Dracup, CEO, Early Diagnostics Institute
    Alexis Webb, Senior Research Funding Manager, Cancer Reserch UK
    Andy Chaloner, CEO, Stream Bio
    Sameer Kothari, Chief Executive Director, Zilico

  • Virtual Coffee, Networking and Pre-booked Partnering Meetings

  • Patient Perspective

    Emily Lam, Public & Patient Involvement, The Clatterbridge Cancer Centre

  • Supporting Drug Discovery

    Chair: Peter Simpson, Chief Scientific Officer, Medicines Discovery Catapult

    Speaker will be announced shortly

  • Virtual Coffee, Networking and Pre-booked Partnering Meetings

  • Supporting Pre-Clinical Development

    Chair: Jane Kendrew, Head of Science Services, Alderley Park
    Speakers
    Juliana Maynard, Lead Scientist, Medicines Discovery Catapult

    Further speakers will be announced shortly

  • Biotech & Beers Networking

  • Virtual Reception Area Open

  • Conference Welcome

    Geoff Davison, CEO, Bionow

  • Charity Perspective

    Alastair Richards, CEO, North West Cancer Research

  • Pharmaceutical Development

    Chair: Paul Stott, CEO, Seda Pharmaceutical Development Services
    Speakers
    Alyn McNaughton, Technical Director, Lonza Group
    Claire Patterson, Senior Principal Scientist, Seda Pharmaceutical Development Services
    Lyn Daintree, Development Director, Crystec Pharma

  • Virtual Coffee, Networking and Pre-booked Partnering Meetings

  • Children & Young Person's Cancer Pathway

    Speaker will be announced shortly.

  • What is the Future?

    Chair: Claire Thompson, CEO, Agility Health
    Panel Members
    Steve McConchie, CEO, Aptus Clinical
    David Howat, Director of Medtech & Therapeutic Development, Stream Bio
    Allan Jordan, Director - Oncology Drug Discovery, Sygnature Discovery

Sponsors

Registration

Member Delegate Pass

  • £135 + VAT

Premium Member Delegate Pass

  • £99 + VAT

Premium Member Company Showcase Package

  • £249 + VAT

Member Company Showcase Package

  • £295 + VAT

Non-Member Company Showcase Package

  • £395 + VAT

Non-Member Delegate Pass

  • £195 + VAT

Company Showcase Packages

Each Company Showcase Package will consist of:- 

  • 1 x Delegate Pass
  • Pre-recorded Company Showcase (3 minutes in length)
  • Showcase uploaded to Event Delegate Area Pre-conference and available Post-conference
  • News Article promoting the Conference and Company showcases with link to pre-recorded material to be circulated to the network and Bionow website / newsletter
  • Social Media Content as a Showcase Company in the run up to the Event
  • Logo on Event page on Bionow website

Please click HERE to view the Company Showcase Guidelines

Sponsorship

There are exciting opportunities available for sponsorship at this event. If you would like further details please contact helen.williams@bionow.co.uk.